Jeffrey A. Kahn, MD

Professor of Clinical Medicine, Acting Chief, Division of GI and Liver Diseases

Is this your profile? Click to edit

Overview

Dr. Kahn is the medical director of the USC Liver Transplant Program. He received fellowship training in gastroenterology and transplant hepatology from the Keck School of Medicine and Cedars-Sinai Medical Center. He is board certified in internal medicine, gastroenterology and transplant hepatology.

Dr. Kahn’s primary research interests are in liver transplantation, hepatocellular carcinoma and viral hepatitis. He has written and co-authored several abstracts and peer-reviewed articles on various topics such as chronic hepatitis C and liver transplantation. He is also a distinguished lecturer.

Awards

Alpha Omega Alpha, 1990

Publications

Sofosbuvir and Simeprevir Therapy for Recurrent Hepatitis C Infection After Liver Transplantation. Transplant Direct. 2015 Jul; 1(6):e21.. View in PubMed
Imaging appearance in acute liver failure: correlation with clinical and pathology findings. Dig Dis Sci. 2014 Aug; 59(8):1987-95.. View in PubMed
Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis C. Gastroenterology. 2010 Jun; 138(7):2321-31.. View in PubMed
Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial. Hepatology. 2006 Dec; 44(6):1675-84.. View in PubMed
Portal hypertensive gastropathy in chronic hepatitis C patients with bridging fibrosis and compensated cirrhosis: results from the HALT-C trial. Am J Gastroenterol. 2006 May; 101(5):983-92.. View in PubMed
Live donor liver transplantation without blood products: strategies developed for Jehovah’s Witnesses offer broad application. Ann Surg. 2004 Aug; 240(2):350-7.. View in PubMed

Jeffrey A. Kahn, MD

Overview

Awards

Publications

Similar People